APA (7th ed.) Citation

Labban, M., Patrick, A., Mahendraratnam Lederer, N., Jao, R., Patel, P., & Jaksa, A. (2022). EE155 The Impact of Value-Based Pricing (VBP) Vs International Reference Pricing (IRP) on Innovative Drugs in the US. Value in Health, 25(7), S364. https://doi.org/10.1016/j.jval.2022.04.404

Chicago Style (17th ed.) Citation

Labban, M., A. Patrick, N. Mahendraratnam Lederer, R. Jao, P. Patel, and A. Jaksa. "EE155 The Impact of Value-Based Pricing (VBP) Vs International Reference Pricing (IRP) on Innovative Drugs in the US." Value in Health 25, no. 7 (2022): S364. https://doi.org/10.1016/j.jval.2022.04.404.

MLA (9th ed.) Citation

Labban, M., et al. "EE155 The Impact of Value-Based Pricing (VBP) Vs International Reference Pricing (IRP) on Innovative Drugs in the US." Value in Health, vol. 25, no. 7, 2022, p. S364, https://doi.org/10.1016/j.jval.2022.04.404.